{"id":2127,"date":"2011-11-01T03:08:35","date_gmt":"2011-11-01T07:08:35","guid":{"rendered":"http:\/\/www.kayak2u.com\/blog\/?p=2127"},"modified":"2011-11-01T03:08:35","modified_gmt":"2011-11-01T07:08:35","slug":"shortage-people","status":"publish","type":"post","link":"https:\/\/www.kayak2u.com\/?p=2127","title":{"rendered":"Shortage people"},"content":{"rendered":"<p>Yesterday, the Obama administration likely issued an Executive Order allegedly addressing the growing incidences of drug shortages. &nbsp;See the <a href=\"http:\/\/www.whitehouse.gov\/the-press-office\/2011\/10\/31\/fact-sheet-obama-administration-takes-action-reduce-prescription-drug-sh\" target=\"_blank\">White House press statement<\/a>, trumpeting the coming order.<\/p>\n<p>The press release is interesting in a number of ways, most of which I can&#39;t take the time to fully address.<\/p>\n<p>While the statement includes several admissions that the bureaucracy is a wrench in the works of excellent and timely drug delivery, there is no call for less bureaucracy. &nbsp;To the contrary, Obama wants the bureaucracy expanded, to better &quot;expedite&quot; the things that the bureaucracy does too slowly now.<\/p>\n<p>One example that illustrates the ignorance (or malfeasance) of the administration is the paragraph titled, &quot;Fighting Price Gouging&quot;. &nbsp;<\/p>\n<p>Price controls. &nbsp;Obama might as well decree further shortages.<\/p>\n<p>The section labeled &quot;Key Facts about Drug Shortages&quot; is a list of a few hard facts interspliced with various nebulous criticisms such as, &quot;&#39;Just in time&#39; manufacturing and inventorying practices leave little margin for error.&quot; &nbsp;Well, that&#39;s true, but why would a company cut things so tightly as to repeatedly fail to meet a customer&#39;s order? &nbsp;To Obama and the rest of the socialists, that&#39;s a mystery.<\/p>\n<p>What ends up providing some pertinent information in relation to the ongoing drug shortages turns out to come from one of the blowhard bloggers <a href=\"http:\/\/www.washingtonpost.com\/blogs\/ezra-klein\/post\/why-a-white-house-order-on-drug-shortages-matters\/2011\/10\/31\/gIQAs0BmZM_blog.html\" target=\"_blank\">working<\/a> Ezra Klein&#39;s Washington Post spot, who highlight the Presidents Executive Order. &nbsp;Ninety nine percent of the post is worthless, but the &quot;<a href=\"http:\/\/www.asahq.org\/For-Members\/Advocacy\/Washington-Alerts\/ASA-Presents-Before-Hundreds-at-FDA-Drug-Shortages-Public-Workshop.aspx\" target=\"_blank\">five recommendations<\/a>&quot; link that leads to the effluvia of the &quot;Drug Shortages Summit Steering Committee&quot;, ostensibly representing a &quot;diverse coalition of health-care industries&quot; who emit a rather non-diverse set of legislative and\/or regulatory proposals contains a couple of giblets that inform the larger picture.<\/p>\n<p>Actually, one most go to the bottom of the aforementioned link, to the <a href=\"http:\/\/www.asahq.org\/For-Members\/Advocacy\/Washington-Alerts\/~\/media\/For%20Members\/Advocacy\/ASA%20in%20Washington\/Regulatory%20and%20Legislative%20Recommendations%20from%20the%20Drug%20Shortages%20Summit%20Steering%20Group.ashx\" target=\"_blank\">five recommendations<\/a> (PDF), before one finds the actual five recommendations alluded to in the Klein blog.<\/p>\n<p>What ARE the five recommendations (severely abbreviated except where not, by me) being pushed by the (allegedly diverse) steering committee?<\/p>\n<blockquote>\n<p>1. &nbsp;Insufficient regulatory resources to manage rapidly escalating drug shortages.<\/p>\n<p>2. Inadequate and incomplete communication of drug shortage information.<\/p>\n<p>3. Lack of contingency plans for critical drugs that are vulnerable to shortages.<\/p>\n<p>4.&nbsp; Inability to quickly respond to shortages of controlled substances.<\/p>\n<p>5. Disincentives to manufacturing older generic injectables.<\/p>\n<\/blockquote>\n<p>While all five entries invoke the regulatory environment, the last two surreptitiously describe a couple of the distortions and limitations the government has laid on the pharmaceutical industry.<\/p>\n<p>To whit, on Issue number 4, it is stated&#8230;&nbsp;<\/p>\n<blockquote>\n<p>Regulations for manufacturing and production quotas for controlled substances may limit the ability of the FDA and manufacturers to address drug shortages in an expedited manner. Section 306 of the Controlled Substances Act (CSA) requires that the Attorney General establish aggregate production quotas for schedule II controlled substances. Quotas are set annually in the fall based on factors such as past sales. While manufacturers can request revised quotas at any time, the process is burdensome and can prolong or exacerbate a drug shortage.<\/p>\n<\/blockquote>\n<p>Get that? &nbsp;There are government imposed quotas on whole ranges of drugs, curtailing the flexibility of manufacturers in meeting demand for same. &nbsp;The panel doesn&#39;t recommend that the quotas be removed, just that the regulatory apparatus respond to quota issues more quickly than it currently does. &nbsp;This is the age old issue that has bedevilled central control authoritarian regimes for decades. &nbsp;One imposes a quota on an industry, then one waits for the quota to be exceeded, then one processes the sundry data, then one attempts to set a new quota, meanwhile the associated manufacturers are in limbo and thinking they might as well hang it up.<\/p>\n<p>No matter how quickly a bureaucracy can emit new quotas, it cannot keep up with the vagaries of the market.<\/p>\n<p>And know that quotas are just one of the government induced problems bedevilling the drug industry.<\/p>\n<p>Price controls are just as pervasive, and just as insidious.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Yesterday, the Obama administration likely issued an Executive Order allegedly addressing the growing incidences of drug shortages. &nbsp;See the White House press statement, trumpeting the coming order. The press release is interesting in a number of ways, most of which I can&#39;t take the time to fully address. While the statement includes several admissions that [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[119,1397],"tags":[],"class_list":["post-2127","post","type-post","status-publish","format-standard","hentry","category-health-care","category-shortages-2"],"_links":{"self":[{"href":"https:\/\/www.kayak2u.com\/index.php?rest_route=\/wp\/v2\/posts\/2127","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.kayak2u.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.kayak2u.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.kayak2u.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.kayak2u.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2127"}],"version-history":[{"count":0,"href":"https:\/\/www.kayak2u.com\/index.php?rest_route=\/wp\/v2\/posts\/2127\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.kayak2u.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2127"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.kayak2u.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2127"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.kayak2u.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2127"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}